# Title
Interindividual O
variability O
in O
acetaminophen B-Chemical
glucuronidation O
by O
human B-Species
liver O
microsomes: O
identification O
of O
relevant O
acetaminophen B-Chemical
UDP-glucuronosyltransferase O
isoforms. O

# Abstract
Interindividual O
variability O
in O
acetaminophen B-Chemical
(APAP) B-Chemical
glucuronidation O
may O
contribute O
to O
differences O
in O
susceptibility O
to O
APAP B-Chemical
intoxication O
in O
humans. B-Species
The O
purpose O
of O
this O
study O
was O
to O
identify O
the O
relevant O
UDP-glucuronosyltransferase O
(UGT) O
isoforms O
mediating O
APAP-UGT O
activity O
in O
human B-Species
liver O
microsomes O
(HLMs). O
APAP-UGT O
activities O
and O
enzyme O
kinetics O
were O
determined O
using O
HLMs O
from O
56 O
donors O
and O
nine O
recombinant O
human B-Species
UGTs. O
Activities O
mediated O
by O
UGT1A1, B-Gene
UGT1A4, B-Gene
UGT1A9, B-Gene
and O
UGT2B7, B-Gene
and O
relative O
UGT1A6 B-Gene
protein O
content O
were O
quantified O
using O
20 O
livers. O
More O
than O
15-fold O
variation O
in O
liver O
microsomal O
APAP-UGT O
activities O
was O
observed O
with O
a O
distribution O
skewed O
toward O
lower O
activities. O
Although O
most O
UGTs O
could O
glucuronidate O
APAP, B-Chemical
UGT1A1, B-Gene
UGT1A6, B-Gene
and O
UGT1A9 B-Gene
were O
most O
active. O
UGT1A6 B-Gene
was O
a O
relatively O
high-affinity O
(K(m) O
= O
2.2 O
mM), O
low-capacity O
enzyme; O
UGT1A1 B-Gene
was O
intermediate O
in O
affinity O
(K(m) O
= O
9.4 O
mM) O
and O
capacity; O
and O
UGT1A9 B-Gene
was O
a O
low-affinity O
(K(m) O
= O
21 O
mM), O
high-capacity O
enzyme. O
K(m) O
values O
were O
similar O
to O
UGT1A1 B-Gene
in O
high- O
and O
intermediate-activity O
HLMs O
(6-10 O
mM) O
and O
UGT1A9 B-Gene
in O
low-activity O
HLMs O
(10-55 O
mM). O
APAP-UGT O
activities O
correlated O
best O
with O
propofol-UGT O
(r O
= O
0.85; O
UGT1A9) B-Gene
and O
bilirubin-UGT O
(r O
= O
0.66; O
UGT1A1) B-Gene
activities, O
but O
poorly O
with O
UGT1A6 B-Gene
protein O
(r O
= O
0.30). O
A O
kinetic O
model O
was O
constructed O
from O
these O
data O
that O
identified O
UGT1A9 B-Gene
as O
the O
predominant O
APAP-UGT O
(>55% O
total O
activity) O
in O
HLMs O
over O
a O
clinically O
relevant O
APAP B-Chemical
concentration O
range O
(50 O
microM-5 O
mM). O
UGT1A1 B-Gene
was O
also O
predicted O
to O
contribute O
substantially O
at O
toxic O
concentrations O
(>1 O
mM; O
>28% O
activity), O
whereas O
UGT1A6 B-Gene
was O
most O
active O
at O
relatively O
low O
concentrations O
(<50 O
microM; O
>29% O
activity). O